Hyperbaric oxygen therapy
Medical Services Advisory Committee
Record ID 32006001510
English
Authors' recommendations:
The clinical evidence was inadequate to substantiate claims that hyperbaric oxygen therapy (HBOT) was cost-effective in the treatment of refractory soft tissue injuries or non-diabetic refractory wounds. However, the MSAC recommended that as there are no effective alternative therapies and in view of the progress of local data collections and an international trial, funding for HBOT continue for MBS listed indications at current eligible sites for a further three years.
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au
Year Published:
2003
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1054-public
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Hyperbaric Oxygenation
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
<p>Medical Services Advisory Committee (MSAC)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.